We are live on ! Find out more
JSP

Jackson Square Partners Portfolio holdings

AUM $247M
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$21.4B
AUM Growth
+$1.44B
Cap. Flow
-$491M
Cap. Flow %
-2.3%
Top 10 Hldgs %
35.67%
Holding
94
New
5
Increased
29
Reduced
48
Closed
8

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$469M
2
MTCH icon
Match Group
MTCH
+$337M
3
WIX icon
WIX.com
WIX
+$158M
4
PLAN
Anaplan, Inc.
PLAN
+$139M
5
PAYC icon
Paycom
PAYC
+$101M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$410M
2
IQV icon
IQVIA
IQV
+$232M
3
MSFT icon
Microsoft
MSFT
+$214M
4
HAE icon
Haemonetics
HAE
+$206M
5
CME icon
CME Group
CME
+$187M

Sector Composition

Rank Sector Weight
1 Technology 34.26%
2 Consumer Discretionary 14.01%
3 Financials 13.56%
4 Communication Services 13.23%
5 Healthcare 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
76
Crown Castle
CCI
$32.3B
-4,501
Closed -$753K
CME icon
77
CME Group
CME
$101B
-1,150,360
Closed -$187M
HAE icon
78
Haemonetics
HAE
$4.68B
-2,298,190
Closed -$206M
LBRDK
79
DELISTED
Liberty Broadband Class C
LBRDK
-2,869
Closed -$355K
STZ icon
80
Constellation Brands
STZ
$21.9B
-4,870
Closed -$852K
ZD icon
81
Ziff Davis
ZD
$1.91B
-898,033
Closed -$49.4M

Similar funds

Jackson Square Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Jackson Square Partners held 94 positions worth $21.4B, up 7.2% from $19.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jackson Square Partners's Q3 2020 filing shows 5 new, 29 increased, 48 reduced and 8 closed positions. Its largest new stake was Edwards Lifesciences: 6,016,819 shares worth $480M. The largest sale was UnitedHealth, an estimated $410M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jackson Square Partners's largest Q3 2020 buy was Edwards Lifesciences: 6,016,819 shares worth $480M.
  • Jackson Square Partners added most to Match Group in Q3 2020, an estimated $337M increase.
  • Jackson Square Partners's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $410M.
  • Jackson Square Partners fully exited Haemonetics in Q3 2020, selling an estimated $206M.
  • Jackson Square Partners's ten largest holdings make up 36% of its $21.4B portfolio in Q3 2020.
  • Jackson Square Partners opened 5 new positions and closed 8 in Q3 2020.
  • Jackson Square Partners's portfolio value rose 7.2% quarter-over-quarter to $21.4B.

Based on Jackson Square Partners's 13F filing for Q3 2020, filed 13 Nov 2020.